# OSRH (OSR Health, Inc.) - SEC EDGAR Financial Statements

> OSR Health, Inc. reported $1.71M in revenue and a net loss of $10.22M for the trailing twelve months ended September 30, 2026 (down 16.4% year over year), with a 24.3% gross margin and a -946.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/OSRH
- Markdown: https://convexityos.com/fundamentals/OSRH.md
- SEC CIK: 0001840425
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001840425&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.71M | -16.4% YoY |
| Operating Income | TTM | -$16.15M | -946.7% margin |
| Net Income | TTM | -$10.22M | -599.0% net margin |
| Diluted EPS | TTM | -$0.80 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.37M | Total debt: $2.91M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.91M | $3.53M | -- | -- | -- |
| Cost of Revenue | $2.31M | $2.72M | -- | -- | -- |
| **Gross Profit** | $593K | $811K | -- | -- | -- |
| Research & Development | $318K | $161K | -- | -- | -- |
| Selling, General & Admin | $18.93M | $12.50M | $1.83M | $35K | $3.3K |
| **Operating Income** | -$18.34M | -$11.69M | -$1.83M | -$35K | -$3.3K |
| **EBITDA** | -$9.03M | -$2.00M | -- | -- | -- |
| Interest Income | $64K | $21K | $2.78M | -- | -- |
| Interest Expense | $506K | $51K | -- | -- | -- |
| Income Before Tax | -$28.89M | -$11.89M | $945K | -- | -- |
| Income Tax Expense | -$1.83M | -$1.56M | $541K | -- | -- |
| **Net Income** | -$18.01M | -$2.41M | $404K | -$35K | -$3.3K |
| Basic EPS | -$0.92 | -$4.79 | $0.05 | -$0.01 | $0.00 |
| **Diluted EPS** | -$0.80 | -$4.79 | $0.05 | -$0.01 | $0.00 |
| Basic Shares Outstanding | 19.5M | 2.2M | 7.7M | 1.5M | 1.5M |
| Diluted Shares Outstanding | 22.6M | 2.2M | 7.7M | 1.5M | 1.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $525K | $316K | $484K | $381K | $628K | $1.14M | $761K | -- |
| Cost of Revenue | $487K | $229K | $324K | $252K | $366K | $1.10M | $593K | $755K |
| **Gross Profit** | $38K | $87K | $160K | $130K | $262K | $33K | $169K | $160K |
| Research & Development | $102K | $95K | $113K | $177K | -$1.8K | $54K | $90K | $14K |
| Selling, General & Admin | $3.10M | $3.12M | $3.83M | $6.52M | $4.07M | $5.26M | $3.09M | $1.77M |
| **Operating Income** | -$3.06M | -$3.03M | -$3.67M | -$6.39M | -$3.80M | -$5.23M | -$2.92M | -$1.61M |
| **EBITDA** | -$570K | -$670K | -$1.24M | -$4.09M | -$1.42M | -$2.88M | -$645K | -$459K |
| Interest Income | $1.8K | $1.5K | $17K | $17K | $18K | $25K | $4.3K | $9.8K |
| Interest Expense | $9.2K | $13K | $31K | $409K | $44K | $37K | $16K | $27K |
| Income Before Tax | -$2.37M | -$1.44M | -$3.92M | -$7.78M | -$4.49M | -$5.23M | -$11.39M | -$1.79M |
| Income Tax Expense | -$465K | -$440K | -$452K | -- | -$1.29M | -- | -- | -$451K |
| **Net Income** | -$1.61M | -$849K | -$2.93M | -$4.82M | -$2.13M | $331K | -$11.39M | -$2.02M |
| Basic EPS | -$0.05 | -$0.02 | -$0.09 | -- | -$0.10 | $0.02 | -$1.04 | -- |
| **Diluted EPS** | -- | -- | -$0.08 | -- | -- | -- | -$1.04 | -- |
| Basic Shares Outstanding | -- | -- | 31.2M | -- | -- | -- | 10.9M | -- |
| Diluted Shares Outstanding | -- | -- | 34.3M | -- | -- | -- | 10.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.70M | $342K | $15K | $125K | $4.8K |
| **Cash & Short-Term Investments** | $1.70M | $342K | $15K | $125K | $4.8K |
| Accounts Receivable, Net | $319K | $904K | -- | -- | -- |
| Inventory | $196K | $922K | -- | -- | -- |
| Other Current Assets | $264K | $75K | -- | -- | -- |
| **Total Current Assets** | $2.82M | $2.33M | $23K | $125K | $4.8K |
| Property, Plant & Equipment, Net | $169K | $2.3K | -- | -- | -- |
| Goodwill | $24.95M | $24.35M | $27.77M | -- | -- |
| Intangible Assets | $142.5M | $148.1M | -- | -- | -- |
| **Total Non-Current Assets** | $168.4M | $172.9M | $36.61M | $1.10M | $700K |
| **Total Assets** | $171.2M | $175.2M | $36.63M | $1.23M | $705K |
| Short-Term Debt | $2.32M | $1.80M | $2.02M | $1.14M | -- |
| Other Current Liabilities | $971K | $80K | $72K | $17K | -- |
| **Total Current Liabilities** | $17.17M | $3.46M | $2.04M | $1.26M | $707K |
| Long-Term Debt | $0 | $498K | -- | -- | -- |
| Other Non-Current Liabilities | $1.7K | $1.7K | -- | -- | -- |
| **Total Non-Current Liabilities** | $27.04M | $28.57M | $2.07M | $0 | $0 |
| **Total Liabilities** | $44.20M | $32.03M | $4.11M | $1.26M | $707K |
| **Total Debt (incl. Leases)** | $2.38M | $2.38M | $2.02M | $1.14M | -- |
| Common Stock | $2.7K | $216 | $216 | $173 | $173 |
| Retained Earnings | -$37.17M | -$19.17M | -$3.91M | -$63K | -$27K |
| Accumulated Other Comp. Income | $3.84M | -$225K | -- | -- | -- |
| **Total Stockholders' Equity** | -- | -$8.33M | -$3.91M | -$38K | -$2.1K |
| Total Equity | $127.0M | $143.2M | $153.5M | -$38K | -$2.1K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.37M | $1.50M | $1.57M | $1.70M | $2.18M | $1.58M | $1.60M | $342K |
| **Cash & Short-Term Investments** | $1.37M | $1.50M | $1.57M | $1.70M | $2.18M | $1.58M | $1.60M | $342K |
| Accounts Receivable, Net | $245K | $189K | $261K | $319K | $489K | $743K | $795K | $904K |
| Inventory | $397K | $594K | $462K | $196K | $185K | $199K | $737K | $922K |
| Other Current Assets | $331K | $372K | $312K | $264K | $251K | $282K | $280K | $75K |
| **Total Current Assets** | $2.48M | $2.87M | $2.92M | $2.82M | $3.20M | $2.88M | $3.47M | $2.33M |
| Property, Plant & Equipment, Net | $152K | $142K | $154K | $169K | $98K | $3.7K | $999 | $2.3K |
| Goodwill | $33.12M | $29.19M | $29.73M | $24.95M | $25.53M | $26.39M | $24.41M | $24.35M |
| Intangible Assets | $149.6M | $134.1M | $139.0M | $142.5M | $148.2M | $155.6M | $146.2M | $148.1M |
| **Total Non-Current Assets** | $183.3M | $163.8M | $169.3M | $168.4M | $174.1M | $182.5M | $171.1M | $172.9M |
| **Total Assets** | $185.8M | $166.6M | $172.2M | $171.2M | $177.3M | $185.4M | $174.6M | $175.2M |
| Short-Term Debt | $2.69M | $2.37M | $2.42M | $2.32M | $1.86M | $2.40M | $1.89M | $1.80M |
| Other Current Liabilities | $1.05M | $967K | $978K | $971K | $963K | $2.13M | $1.00M | $80K |
| **Total Current Liabilities** | $16.68M | $15.73M | $17.90M | $17.17M | $15.03M | $15.86M | $13.88M | $3.46M |
| Long-Term Debt | $198K | $271K | $273K | $0 | $0 | -- | $253K | $498K |
| Other Non-Current Liabilities | $77K | $67K | $67K | $1.7K | $1.7K | $1.8K | $1.7K | $1.7K |
| **Total Non-Current Liabilities** | $28.88M | $25.98M | $26.90M | $27.04M | $28.10M | $30.41M | $28.38M | $28.57M |
| **Total Liabilities** | $45.56M | $41.71M | $44.80M | $44.20M | $43.13M | $46.26M | $42.27M | $32.03M |
| **Total Debt (incl. Leases)** | $2.91M | $2.68M | $2.74M | $2.38M | $1.91M | $2.46M | $2.22M | $2.38M |
| Common Stock | $3.5K | $3.5K | $3.3K | $2.7K | $2.4K | $2.0K | $1.9K | $216 |
| Retained Earnings | -$42.56M | -$40.95M | -$40.10M | -$37.17M | -$32.33M | -$30.18M | -$30.57M | -$19.17M |
| Accumulated Other Comp. Income | $12.87M | -$2.08M | -$1.66M | $3.84M | $4.72M | $6.98M | $242K | -$225K |
| **Total Stockholders' Equity** | -- | -- | -- | -- | -- | -- | -- | -$8.33M |
| Total Equity | $140.2M | $124.9M | $127.4M | $127.0M | $134.2M | $139.2M | $132.3M | $143.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$27.06M | -$10.33M | $404K | -$35K | -$3.3K |
| Depreciation & Amortization | $9.31M | $9.69M | -- | -- | -- |
| Change in Inventory | $764K | $306K | -- | -- | -- |
| Change in Payables | -$510K | -$344K | -- | -- | -- |
| **Operating Cash Flow** | -$4.33M | -$1.85M | -$819K | -$4.2K | -$461 |
| Acquisitions, Net | $1.22M | -- | -- | -- | -- |
| Purchases of Investments | -- | -$480K | -$180K | -- | -- |
| **Investing Cash Flow** | -$2.64M | $504K | -$33.83M | -- | -- |
| Common Stock Issued | $4.80M | -- | $9.16M | -- | -- |
| Share Repurchases | -- | -$36.23M | -$36.00M | -- | -- |
| **Financing Cash Flow** | $8.37M | $1.18M | $34.54M | $124K | -$57K |
| **Net Change in Cash** | $1.40M | -$162K | -$109K | $120K | -$58K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.91M | -$1.00M | -$3.47M | -$7.25M | -$3.19M | -$5.23M | -$11.39M | -$1.34M |
| Depreciation & Amortization | $2.49M | $2.36M | $2.43M | $2.29M | $2.39M | $2.35M | $2.27M | $1.15M |
| Change in Inventory | $210K | -$145K | -$66K | $772K | -$781K | $583K | $189K | $34K |
| Change in Payables | -$313K | -$970K | $11K | $75K | -$1.62M | $1.01M | $22K | $249K |
| **Operating Cash Flow** | -$371K | -$2.42M | -$1.00M | -$1.07M | -$2.71M | -$483K | -$64K | -$181K |
| Acquisitions, Net | -- | -$136 | $11K | -$8.2K | $13K | $21K | $1.20M | -- |
| **Investing Cash Flow** | -$188K | -$88K | $12K | -$2.57M | -$727K | -$528K | $1.19M | -$188K |
| Common Stock Issued | $215K | $1.26M | $845K | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $247K | $2.47M | $942K | $3.21M | $4.12M | $891K | $149K | $322K |
| **Net Change in Cash** | -$311K | -$36K | -$48K | -$432K | $678K | -$120K | $1.27M | -$47K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 20.4% | 23.0% | -- | -- | -- |
| **Operating Margin** | -631.0% | -331.2% | -- | -- | -- |
| **Net Profit Margin** | -619.8% | -68.3% | -- | -- | -- |
| Return on Assets (ROA) | -10.5% | -1.4% | 1.1% | -2.9% | -0.5% |
| Current Ratio | 0.16x | 0.67x | 0.01x | 0.10x | 0.01x |
| Quick Ratio | 0.15x | 0.41x | 0.01x | 0.10x | 0.01x |
| **Revenue Growth (YoY)** | -17.7% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -26.9% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -697.1% | -- | -- | -- |
| EPS Growth (YoY) | -- | -9680.0% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 24.3% | 35.3% | 22.2% | 20.4% | -- | -- | -- | -- |
| **Operating Margin** | -946.7% | -933.7% | -726.1% | -631.0% | -- | -- | -- | -- |
| **Net Profit Margin** | -599.0% | -593.2% | -363.3% | -619.8% | -- | -- | -- | -- |
| Return on Assets (ROA) | -5.5% | -6.4% | -5.5% | -10.5% | -8.6% | -7.2% | -7.9% | -1.4% |
| Current Ratio | 0.15x | 0.18x | 0.16x | 0.16x | 0.21x | 0.18x | 0.25x | 0.67x |
| Quick Ratio | 0.12x | 0.14x | 0.14x | 0.15x | 0.20x | 0.17x | 0.20x | 0.41x |
| **Revenue Growth (YoY)** | -16.4% | -72.2% | -36.4% | -- | -23.7% | +28.8% | -16.4% | -- |
| Gross Profit Growth (YoY) | -85.5% | +164.2% | -5.0% | -18.9% | +46.1% | -85.9% | -29.7% | -- |
| **Net Income Growth (YoY)** | -- | -356.1% | -- | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -200.0% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
